Marker Therapeutics Inc (NASDAQ:MRKR)

0.3351
Delayed Data
As of May 17
 +0.0251 / +8.10%
Today’s Change
0.28
Today|||52-Week Range
3.65
-64.73%
Year-to-Date
No recent news for Marker Therapeutics Inc.

Today’s Trading

Previous close0.31
Today’s open0.32
Day’s range0.31 - 0.35
Volume165,806
Average volume (3 months)615,139
Market cap$27.4M
Data as of 05/17/2022

Growth & Valuation

Earnings growth (last year)+10.29%
Earnings growth (this year)+15.91%
Earnings growth (next 5 years)--
Revenue growth (last year)+166.01%
P/E ratio--
Price/Sales58.54
Price/Book0.62

Competitors

----
ATHEAlterity Therapeutic...+0.03+4.62%
----
AGEAgeX Therapeutics In...+0.02+2.73%
Data as of 05/17/2022

Financials

Next reporting dateAugust 11, 2022
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$1.2M
Annual profit (last year)-$41.9M
Net profit margin-3,372.68%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Houston, Texas

Forecasts